SCHEMBL2445278

SCHEMBL2445278

COc1ccc(Cl)cc1-c1nnc(CCN2CCc3nc4ccccc4c(C4CN(C=O)CCO4)c3C2)o1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.35
▸ L3MBTL1 Q9Y468 4/20 0.35
▸ MAPT P10636 3/20 0.35
▸ POLB P06746 2/20 0.35
▸ ADRA2A P08913 4/20 0.34
▸ ADRA2B P18089 4/20 0.34
▸ ADRA2C P18825 4/20 0.34
▸ ADRA1A P35348 3/20 0.34
▸ ANO1 Q5XXA6 1/20 0.34
▸ ANO2 Q9NQ90 1/20 0.34
▸ LMNA P02545 3/20 0.34
▸ ABCB1 P08183 2/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ CYP2C9 P11712 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ PTGS2 P35354 1/20 0.34
▸ MAPK1 P28482 5/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2448522 0.82 ALDH1A1 (0.42) ALDH1A1L3MBTL1MAPTPOLBLMNA
SCHEMBL2321775 0.79 ALDH1A1 (0.43) ALDH1A1L3MBTL1MAPTPOLBLMNA
SCHEMBL2448128 0.75 ALDH1A1 (0.49) ALDH1A1L3MBTL1MAPTPOLBLMNA
SCHEMBL2448725 0.75 KMT2A (0.55) ALDH1A1L3MBTL1MAPTPOLBLMNA
SCHEMBL2320715 0.74 ALDH1A1 (0.52) ALDH1A1L3MBTL1MAPTPOLBANO1
SCHEMBL2446015 0.71 KMT2A (0.45) ALDH1A1L3MBTL1MAPTPOLBLMNA
SCHEMBL2317915 0.71 ALDH1A1 (0.52) ALDH1A1L3MBTL1MAPTPOLBLMNA
SCHEMBL2447811 0.71 ALDH1A1 (0.54) ALDH1A1L3MBTL1MAPTPOLBLMNA
SCHEMBL2442492 0.70 ALDH1A1 (0.51) ALDH1A1L3MBTL1MAPTPOLBLMNA
SCHEMBL2446700 0.69 ALDH1A1 (0.49) ALDH1A1L3MBTL1MAPTPOLBADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110230471-A1 BENZONAPHTYRIDINE COMPOUNDS AS INHIBITORS OF AUTOTAXIN MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2011-09-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110230471-A1 BENZONAPHTYRIDINE COMPOUNDS AS INHIBITORS OF AUTOTAXIN ENPP2, TPX2, TPD52L2 ALDH1A1 4584/4885L3MBTL1 206/4885MAPT 2887/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback